drugset / Trial / NCT01630850

Islet Transplantation in Patients With "Brittle" Type I Diabetes

NCT01630850 ↗

Recruiting 20 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.

Timeline

Start
2012-05
Primary completion
2030-06
Completion
2030-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogenic islet cells Cell therapy — Other